Zars Topical Anesthetic Peel Approved For Dermatological Procedures
This article was originally published in The Pink Sheet Daily
Executive Summary
The lidocaine/tetracaine topical anesthetic joins Zars’ Synera combo patch, launched in June by marketing partner Endo.
You may also be interested in...
Endo Financials Strong, But Shareholder Calls For Sale Of Company
CEO stepping down and no R&D leader on board, as officials evaluate pipeline.
Forest Files Memantine/Donepezil Fixed Combination For Alzheimer’s
Commercialization of the fixed-dose combo buys lifecycle management for Forest and should support future drug development for partner Adamas, the originator of the technology behind the combination.